Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

459 trials with published results (34%)

Research Maturity

1103 completed trials (81% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

3.1%

43 terminated out of 1367 trials

Success Rate

96.2%

+9.7% vs benchmark

Late-Stage Pipeline

36%

494 trials in Phase 3/4

Results Transparency

42%

459 of 1103 completed with results

Key Signals

459 with results96% success43 terminated

Data Visualizations

Phase Distribution

1,196Total
Not Applicable (170)
P 1 (257)
P 2 (275)
P 3 (265)
P 4 (229)

Trial Status

Completed1,103
Unknown82
Recruiting54
Terminated43
Withdrawn33
Active Not Recruiting32

Trial Success Rate

96.2%

Benchmark: 86.5%

Based on 1103 completed trials

Clinical Trials (1367)

Showing 20 of 20 trials
NCT07149428Not Yet Recruiting

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

NCT06850298Not ApplicableRecruitingPrimary

H5N1 Milk Detection Study

NCT06609811Phase 4CompletedPrimary

The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine

NCT01386424Recruiting

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

NCT05648448Phase 2RecruitingPrimary

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

NCT07215858Phase 2RecruitingPrimary

BPL-1357 Against H1N1 Influenza Virus Challenge

NCT05266222RecruitingPrimary

Respiratory Virus Sampling and Repository

NCT01191853Completed

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines

NCT07110532Phase 1RecruitingPrimary

pH1N1 Blinded Challenge Study

NCT07516977Not ApplicableNot Yet Recruiting

Noseguard for Prevention of Respiratory Infections in Real-World Use

NCT04794829RecruitingPrimary

Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

NCT05832307Not ApplicableRecruitingPrimary

The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

NCT07508189Not ApplicableActive Not RecruitingPrimary

Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho

NCT03734237Phase 4Active Not RecruitingPrimary

A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD

NCT07496736Phase 3Active Not RecruitingPrimary

Post-exposure Influenza Prophylaxis in a Hospital Setting

NCT07503405Phase 2Not Yet RecruitingPrimary

Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model

NCT05160636Active Not Recruiting

A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza

NCT06501963Phase 4CompletedPrimary

Revealing Protective Immunity to Influenza Using Systems Immunology

NCT07496450Phase 3RecruitingPrimary

A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults

NCT07371650Phase 2Active Not RecruitingPrimary

This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza

Scroll to load more

Research Network

Activity Timeline